Moore Duncan
Transaction: 03/18/2026
OTHER
Change
+4,667
Price
$0.03
Filing
04/17/2026
Type
OTHER
GH Research PLC
GHRS • Biotechnology
$28.23
▲ +0.31 (+1.11%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.75B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 34.13Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$28.23
Change1.11%
Shares Out62.03M
Market Cap$1.75B
Enterprise Value$1.48B
52W Range11.32 - 28.32
Beta1.31
P/E-31.04
P/B6.65
P/FCF-37.65
EV/EBITDA-25.43
EV/FCF-31.91
Price$28.23
Change1.11%
Shares Out62.03M
Market Cap$1.75B
Enterprise Value$1.48B
52W Range11.32 - 28.32
Beta1.31
P/E-31.04
P/B6.65
P/FCF-37.65
EV/EBITDA-25.43
EV/FCF-31.91
Earnings Yield-3.22%
FCF Yield-2.66%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio34.13
Quick Ratio34.13
Target$48.83
Target Upside72.97%
Target Median$42.00
Target Range39.00 - 65.00
Volume275.64K
Avg Volume248.39K
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 34.13Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
100/100
Bullish
Bullish
9
Hold
0
Bearish
0
Price Target
2026-06-29
Low
$32.00
Mean
$40.57
Median
$39.00
High
$65.00
Insider Transactions
Recent executive and insider activity
Moore Duncan
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/17/2026
Type
OTHER
Ryan Julie
Transaction: 03/18/2026
OTHER
Change
+30,000
Price
$0.03
Filing
04/02/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Moore Duncan | OTHER | +4,667 | $0.03 | 03/18/2026 | 04/17/2026 |
| Moore Duncan | OTHER | 0 | Not reported | 03/18/2026 | 04/17/2026 |
| Ryan Julie | OTHER | +30,000 | $0.03 | 03/18/2026 | 04/02/2026 |
| Valcheva Velichka | OTHER | +300,000 | $0.03 | 03/18/2026 | 04/02/2026 |
| Forer Michael | OTHER | +4,667 | $0.03 | 03/18/2026 | 04/02/2026 |
| Forer Michael | OTHER | 0 | Not reported | 03/18/2026 | 04/02/2026 |
| Halle Magnus Clemensen | OTHER | +50,000 | $0.03 | 03/18/2026 | 04/02/2026 |
| Halle Magnus Clemensen | OTHER | 0 | Not reported | 03/18/2026 | 04/02/2026 |
| Hanley Dermot John | OTHER | +4,667 | $0.03 | 03/18/2026 | 04/02/2026 |
| Hanley Dermot John | OTHER | 0 | Not reported | 03/18/2026 | 04/02/2026 |
| Cameron Aaron Luke | OTHER | +25,000 | $5.80 | 03/18/2026 | 04/02/2026 |
| Schonharting Florian | OTHER | 0 | Not reported | 04/01/2026 | 04/01/2026 |